Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)

SIMPLE SUMMARY: Our previous preclinical trial in a head and neck squamous cell carcinoma (HNSCC) xenograft model showed a high potential for the improvement of curative treatment outcome upon the combination treatment of a radiolabeled (Yttrium-90) anti-EGFR antibody (Cetuximab) and external radiot...

Descripción completa

Detalles Bibliográficos
Autores principales: Rassamegevanon, Treewut, Feindt, Louis, Koi, Lydia, Müller, Johannes, Freudenberg, Robert, Löck, Steffen, Sihver, Wiebke, Çevik, Enes, Kühn, Ariane Christel, von Neubeck, Cläre, Linge, Annett, Pietzsch, Hans-Jürgen, Kotzerke, Jörg, Baumann, Michael, Krause, Mechthild, Dietrich, Antje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615625/
https://www.ncbi.nlm.nih.gov/pubmed/34830750
http://dx.doi.org/10.3390/cancers13225595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615625/
https://www.ncbi.nlm.nih.gov/pubmed/34830750
http://dx.doi.org/10.3390/cancers13225595

Ejemplares similares